Are any of you participating in a phase 1 or phase 2 trial studying an alternative to the radioligand Pluvicto?
I ask because I was one business day away from getting my first dose of Pluvicto when new patients were turned away due to quality control problems. Based on part of the Novartis news release late last week (shown below) new patients like me may be hosed for the rest of 2023.
Thanks.
+++++++++++++++
In the letter, the company said that it currently only manufactures Pluvicto in Italy in "small batches," and is awaiting FDA approval on a new manufacturing site. That approval was expected to come in four to six months, Novartis said. Novartis said it will not take any new orders until there is "clarity on the FDA's approval" of its new manufacturing facility.
Written by
tallguy2
To view profiles and participate in discussions please or .
Oh no! We're waiting too! He's on nothing but Lupron right now. We meet with Dr. V at the University of Michigan on April 3rd. I'll let you know what she says.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.